Today, the U.S. Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter (OTC) monograph drug products for the ...

The FDA announced on Thursday a proposed order to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) ...

Clenbuterol has not been approved by the U.S. Food and Drug Administration (FDA) as an ingredient for any drugs for humans, ...

The Bronchodilator Drugs market in Puerto Rico is anticipated to witness a significant growth in revenue, with projections indicating that it will reach a staggering US$10.15m by 2024. This ...

The Bronchodilator Drugs market in South Korea is forecasted to achieve a revenue of US$0.37bn in 2024. It is expected to exhibit a compound annual growth rate (CAGR) of 3.99% from 2024 to 2029 ...

Cholinergic drugs (acetylcholine and methacholine ... Tiotropium, the first-choice long-acting bronchodilator in COPD, has been studied in severe asthmatics and in COPD patients with a history ...

A new study reveals that ensifentrine, a novel COPD treatment, significantly reduces COPD-related healthcare usage over 48 ...

Trials using oral dosing of labeled and unlabeled drug have demonstrated that the ... Patients included those inadequately controlled with bronchodilators alone (Trial 1), those already receiving ...

Increased risk of serotonin syndrome with serotonergic drugs (eg, SSRIs ... of systolic and diastolic blood pressures and weak bronchodilator and respiratory stimulant action.

This study highlights the benefits of anti-inflammatory inhalers in asthma management, showing reduced complications and ...

From ketones to caffeine, the 'Bomba' and 'Magic Box', French agencies concerned riders are being over-medicated ...

Ohtuvayre™ (ensifentrine) launch recorded Q3 net sales of $5.6 million and October net sales exceeded Q3Through October more than 2,200 unique ...